Lindus Health announces “All-in-One Ophthalmology CRO”

(Image Credit: AdobeStock/NatthyDigitalArt)

Lindus Health announced its “All-in-One Ophthalmology CRO,” a contract research organization and technology solution for the execution of ophthalmology clinical trials.

According to the company, it will help sponsors “navigate the complexities of ophthalmology research and equip them with everything they need to run efficient, patient-centric clinical trials.” Furthermore, the “All-in-One ophthalmology CRO” will assist in covering the development of prescription-grade and over-the-counter products for myopia, macular degeneration, diabetic retinopathy, dry eye, and more.¹

The company also states it can achieve study milestones in clinical trials twice as fast as traditional CROs by collaborating with ophthalmologists, optometrists, and primary care physicians with its unique approach to end-to-end trial execution, enabling ophthalmology sponsors to run highly effective and efficient clinical trials.¹

Features of the “All-in-One Ophthalmology CRO” include:¹

• Comprehensive CRO services:
• Advanced recruitment strategies:
• Tailored eClinical software:
• Industry and regulatory expertise:
• Dedicated site services:

"We use novel approaches to patient retention and engagement, such as 'micro-payments' for completing study activities, personalized outreach and support to participants, and improved patient information and training. This allows us to successfully recruit and execute ophthalmology trials," said Michael Young, co-founder, Lindus Health. "We're incredibly excited to debut our one-of-a-kind CRO and technology offering within this market segment."

Lindus Health describes itself as an “anti-CRO,” and has delivered clinical trials across the US, UK, and Europe in diabetes, asthma, acne, social anxiety, major depressive disorder, hypertension, chronic fatigue syndrome and insomnia.

References:

1. Lindus Health Launches "All-in-One Ophthalmology CRO" Tailored to Clinical Trials in Ophthalmology. Press Release; September 4, 2024. Accessed September 5, 2024. https://www.prnewswire.com/news-releases/lindus-health-launches-all-in-one-ophthalmology-cro-tailored-to-clinical-trials-in-ophthalmology-302237690.html